Search arXivSearch

arXiv · 2009.11747

Distributed Community Detection for Large Scale Networks Using Stochastic Block Model

Abstract

With rapid developments of information and technology, large scale network data are ubiquitous. In this work we develop a distributed spectral clustering algorithm for community detection in large scale networks. To handle the problem, we distribute l pilot network nodes on the master server and the others on worker servers. A spectral clustering algorithm is first conducted on the master to select pseudo centers. The indexes of the pseudo centers are then broadcasted to workers to complete distributed community detection task using a SVD type algorithm. The proposed distributed algorithm has three merits. First, the communication cost is low since only the indexes of pseudo centers are communicated. Second, no further iteration algorithm is needed on workers and hence it does not suffer from problems as initialization and non-robustness. Third, both the computational complexity and the storage requirements are much lower compared to using the whole adjacency matrix. A Python package DCD (www.github.com/Ikerlz/dcd) is developed to implement the distributed algorithm for a Spark system. Theoretical properties are provided with respect to the estimation accuracy and mis-clustering rates. Lastly, the advantages of the proposed methodology are illustrated by experiments on a variety of synthetic and empirical datasets.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Shihao Wu, Zhe Li, Xuening Zhu. 2021-05-31. Distributed Community Detection for Large Scale Networks Using Stochastic Block Model. https://arxiv.org/abs/2009.11747

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

Considerations for the Integration of Randomized Controlled Trials and Real-World Data

As clinical decision-making increasingly moves toward individualized and context-specific treatment recommendations, reliance on any single evidence source, randomized or observational, may be insufficient. Principled integration of randomized controlled trials and real-world data, grounded in explicit causal frameworks, offers a path toward evidence that is both internally credible and externally relevant. In this article, we describe distinct objectives for the integration of randomized controlled trials and real-world data and discuss how these objectives shape key design and analytic considerations, illustrating the resulting choices through example estimands. We highlight practical issues that commonly arise in applied settings, including data relevance and curation, cross-source comparability, estimand specification, and sensitivity analysis. We aim for this article to help readers evaluate and implement principled approaches to integrating randomized controlled trials and real-world data in ways that can support more reliable treatment recommendations while maintaining regulatory-grade evidentiary standards.

stat.ME

Validity of MMRM-based hypothesis testing under missing-not-at-random mechanisms

In randomized clinical trials with longitudinal continuous outcomes, missing-not-at-random (MNAR) missingness often motivates conservative alternatives to mixed models for repeated measures (MMRM). Such caution is important for estimation, but estimation and testing need not require identical assumptions. Moreover, overly conservative primary analyses may reduce power, increase required sample size, and raise trial costs. We investigated the validity of MMRM-based testing under the global null of identical longitudinal outcome distributions across groups. Because valid testing minimally requires treatment-effect estimators to converge to the null under the null hypothesis, we investigated sufficient conditions for this property. We introduced a proportional observation condition requiring ratios of observation probabilities relative to a reference group, conditional on the full outcome vector, to be outcome-independent, and showed that, with arbitrary post-baseline visits and monotone missingness, this condition is sufficient for convergence to the null value. The condition allows observation to depend on unobserved outcomes and permits between-group differences in overall observation probabilities through outcome-independent dropout, making it clinically interpretable while accommodating outcome-dependent MNAR missingness. Synthetic and data-based bootstrap simulations showed negligible bias and empirical test sizes near 0.05, including nonmonotone missingness. Thus, MNAR missingness does not by itself imply that a more conservative primary testing procedure is required. This result does not justify treatment-effect estimation under alternatives, which still requires estimand-based interpretation and sensitivity analyses.

stat.ME

Optimized variance estimation under interference and complex experimental designs

Unbiased and consistent variance estimators generally do not exist for design-based treatment effect estimators because experimenters never observe more than one potential outcome for any unit. The problem is exacerbated by interference and complex experimental designs. Experimenters must accept conservative variance estimators in these settings, but they can strive to minimize the conservativeness. In this paper, we show that the task of constructing a minimally conservative variance estimator can be interpreted as an optimization problem that aims to find the lowest estimable upper bound of the true variance given the experimenter's risk preferences and knowledge of the potential outcomes. We characterize the set of admissible bounds in the class of quadratic forms, and we demonstrate that the optimization problem is a convex program for many natural objectives. The resulting variance estimators are guaranteed to be conservative regardless of whether the background knowledge used to construct the bound is correct, but the estimators are less conservative if the provided information is reasonably accurate. Numerical results show that the resulting variance estimators can be considerably less conservative than existing estimators, allowing experimenters to draw more informative inferences about treatment effects.

stat.ME